The store will not work correctly when cookies are disabled.
(4-Hydroxypiperidin-1-yl)(5-methyl-2-(pyridin-4-yl)phenyl)-methanone
ID: ALA5278891
Max Phase: Preclinical
Molecular Formula: C18H20N2O2
Molecular Weight: 296.37
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ccc(-c2ccncc2)c(C(=O)N2CCC(O)CC2)c1
Standard InChI: InChI=1S/C18H20N2O2/c1-13-2-3-16(14-4-8-19-9-5-14)17(12-13)18(22)20-10-6-15(21)7-11-20/h2-5,8-9,12,15,21H,6-7,10-11H2,1H3
Standard InChI Key: NVQOOURGCFKWOU-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
36.8825 -10.5120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8813 -11.3370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.5941 -11.7488 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3085 -11.3365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3056 -10.5084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.5923 -10.1004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.5957 -12.5692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8816 -12.9798 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8811 -13.8017 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.5939 -14.2140 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.3089 -13.7984 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3058 -12.9779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.5898 -9.2777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1685 -11.7478 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1678 -12.5704 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.4564 -11.3359 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.4565 -10.5090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.7483 -10.0973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0332 -10.5045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0306 -11.3281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.7431 -11.7444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3226 -10.0899 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
3 7 1 0
6 13 1 0
2 14 1 0
14 15 2 0
14 16 1 0
16 17 1 0
16 21 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
19 22 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 296.37 | Molecular Weight (Monoisotopic): 296.1525 | AlogP: 2.65 | #Rotatable Bonds: 2 |
Polar Surface Area: 53.43 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.73 | CX LogP: 1.53 | CX LogD: 1.53 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.93 | Np Likeness Score: -0.87 |
References
1. Koike T, Yoshikawa M, Ando HK, Farnaby W, Nishi T, Watanabe E, Yano J, Miyamoto M, Kondo S, Ishii T, Kuroita T.. (2021) Discovery of Soticlestat, a Potent and Selective Inhibitor for Cholesterol 24-Hydroxylase (CH24H)., 64 (16.0): [PMID:34387987] [10.1021/acs.jmedchem.1c00864] |